ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $796,505 | -10.7% | 29,348 | +1.2% | 0.00% | -33.3% |
| Q2 2023 | $891,460 | -19.5% | 29,000 | -5.6% | 0.00% | 0.0% |
| Q1 2023 | $1,106,986 | -33.5% | 30,724 | -27.0% | 0.00% | -50.0% |
| Q4 2022 | $1,663,832 | -2.8% | 42,101 | -1.2% | 0.01% | -14.3% |
| Q3 2022 | $1,712,000 | +2.3% | 42,602 | +7.0% | 0.01% | +16.7% |
| Q2 2022 | $1,674,000 | -18.9% | 39,824 | -24.8% | 0.01% | +50.0% |
| Q1 2022 | $2,063,000 | -25.4% | 52,966 | -23.7% | 0.00% | -20.0% |
| Q4 2021 | $2,767,000 | -23.1% | 69,435 | -30.3% | 0.01% | -50.0% |
| Q3 2021 | $3,600,000 | +19.2% | 99,611 | +35.1% | 0.01% | +11.1% |
| Q2 2021 | $3,021,000 | +25.2% | 73,712 | +33.3% | 0.01% | +12.5% |
| Q1 2021 | $2,413,000 | -21.5% | 55,314 | -10.0% | 0.01% | -27.3% |
| Q4 2020 | $3,075,000 | – | 61,432 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |